Estimated collective effective dose to the population from X-ray and nuclear medicine examinations in Finland

Abstract Contemporary collective effective doses to the population from x-ray and nuclear medicine examinations in Finland in 2018 was estimated. The estimated effective dose per caput from x-ray examinations increased from year 2008 to 2018 respectively from 0.45 mSv to 0.72 mSv and from nuclear medicine examinations from 0.03 mSv to 0.04 mSv. The proportional dose due to CT examinations of the total collective effective dose from all x-ray examinations increased from 58% in 2008 to 70% in 2018 and the dose did not change substantially in total when new conversion factors were applied. The collective effective dose from conventional plain radiography did not change substantially during the last ten years while the new (ICRP 103) tissue weighting factors were taken into use in 2018, however frequencies of examinations in total decreased. The collective effective dose from CT in nuclear medicine tripled between 2009 and 2018.

Download Full-text

Collective effective dose in Europe from X-ray and nuclear medicine procedures

Radiation Protection Dosimetry ◽

10.1093/rpd/ncv094 ◽

2015 ◽

Vol 165 (1-4) ◽

pp. 129-132 ◽

Cited By ~ 4

Author(s):

R. Bly ◽

A. Jahnen ◽

H. Järvinen ◽

H. Olerud ◽

J. Vassileva ◽

...

Keyword(s):

Nuclear Medicine ◽

Effective Dose ◽

X Ray ◽

Nuclear Medicine Procedures

Download Full-text

Radiation exposure of patients undergoing nuclear medicine procedures in Germany between 1996 and 2000

Nuklearmedizin ◽

10.1055/s-0038-1625201 ◽

2005 ◽

Vol 44 (05) ◽

pp. 119-130 ◽

Cited By ~ 10

Author(s):

P. Schnell-Inderst ◽

D. Noßke ◽

M. Weiss ◽

A. Stamm-Meyer ◽

G. Brix ◽

...

Keyword(s):

Nuclear Medicine ◽

Cardiovascular System ◽

Effective Dose ◽

Current Status ◽

Annual Number ◽

Statistical Parameters ◽

Public Health Information ◽

Nuclear Medicine Procedures ◽

And Gender ◽

Icrp Publication

Summary:The aim of this study was to estimate both the frequency and effective dose of nuclear medicine procedures performed in Germany between 1996 and 2000 for different subgroups of patients. Methods: Electronically archived data from 14 hospitals and 10 private practices were restored and statistically analyzed. The effective dose per examination was calculated according to ICRP publication 80 using the tissue weighting factors given in ICRP publication 60. Based on the data collected, statistical parameters were computed to characterize the frequency and effective dose of the various nuclear medicine procedures. Results: In total, 604,771 nuclear medicine procedures performed in 433,709 patients were analyzed. On average, 1.4 examinations were carried out per patient and year. The median effective dose was 1.7 [5.-95. percentile; mean: 0.4–8.5; 2.9] mSv per examination and 2.3 [0.5–11.2; 3.5] mSv per patient. Interestingly, the mean effective dose per examination, but not the number of examinations per year increased with the age of the patients. Most frequent were examinations of the thyroid (36.7%), the skeleton (27.1%) and the cardiovascular system (11.1%), which were associated with a median effective dose of 0.5 [0.5–1.1; 0.7] mSv, 3.4 [2.9–5.1; 3.6] mSv and 7.3 [3.2–21.0; 9.5] mSv, respectively. Over the five-year period examined, the total annual number of PET procedures (222.3%) as well as of examinations of thyroid (24.5%), skeleton (17.9%), and the cardiovascular system (14.9%) increased markedly, whereas a decrease was observed for brain (-39.3%), lung (-20.2%) and renal (-15.0%) scans. Conclusion: The age- and gender-specific data presented in this study provide detailed public health information on both the current status and recent trends in the practice of diagnostic nuclear medicine examinations.

Download Full-text

Radiation exposure of the staff at the therapeutic and diagnostic nuclear medicine department

Nuklearmedizin ◽

10.3413/nukmed-0163 ◽

2008 ◽

Vol 47 (04) ◽

pp. 175-177 ◽

Cited By ~ 4

Author(s):

J. Dolezal

Keyword(s):

Nuclear Medicine ◽

Radiation Exposure ◽

Effective Dose ◽

Radiation Protection ◽

Annual Effective Dose ◽

Protection Measures ◽

Professional Groups ◽

Personal Dosimetry ◽

The Mean ◽

Administered Activity

SummaryAim: To assess a radiation exposure and the quality of radiation protection concerning a nuclear medicine staff at our department as a six-year retrospective study. Therapeutic radionuclides such as 131I, 153Sm, 186Re, 32P, 90Y and diagnostic ones as a 99mTc, 201Tl, 67Ga, 111In were used. Material, method: The effective dose was evaluated in the period of 2001–2006 for nuclear medicine physicians (n = 5), technologists (n = 9) and radiopharmacists (n = 2). A personnel film dosimeter and thermoluminescent ring dosimeter for measuring (1-month periods) the personal dose equivalent Hp(10) and Hp(0,07) were used by nuclear medicine workers. The wearing of dosimeters was obligatory within the framework of a nationwide service for personal dosimetry. The total administered activity of all radionuclides during these six years at our department was 17,779 GBq (99mTc 14 708 GBq, 131I 2490 GBq, others 581 GBq). The administered activity of 99mTc was similar, but the administered activity of 131I in 2006 increased by 200%, as compared with the year 2001. Results: The mean and one standard deviation (SD) of the personal annual effective dose (mSv) for nuclear medicine physicians was 1.9 ± 0.6, 1.8 ± 0.8, 1.2 ± 0.8, 1.4 ± 0.8, 1.3 ± 0.6, 0.8 ± 0.4 and for nuclear medicine technologists was 1.9 ± 0.8, 1.7 ± 1.4, 1.0 ± 1.0, 1.1 ± 1.2, 0.9 ± 0.4 and 0.7 ± 0.2 in 2001, 2002, 2003, 2004, 2005 and 2006, respectively. The mean (n = 2, estimate of SD makes little sense) of the personal annual effective dose (mSv) for radiopharmacists was 3.2, 1.8, 0.6, 1.3, 0.6 and 0.3. Although the administered activity of 131I increased, the mean personal effective dose per year decreased during the six years. Conclusion: In all three professional groups of nuclear medicine workers a decreasing radiation exposure was found, although the administered activity of 131I increased during this six-year period. Our observations suggest successful radiation protection measures at our department.

Download Full-text

67. The effective dose to children and adolescents from nuclear medicine procedures

Nuclear Medicine Communications ◽

10.1097/00006231-199804000-00075 ◽

1998 ◽

Vol 19 (4) ◽

pp. 377

Author(s):

&NA;

Keyword(s):

Nuclear Medicine ◽

Children And Adolescents ◽

Effective Dose ◽

Nuclear Medicine Procedures

Download Full-text

Russian practical guidance on radiological support for justification of X-ray and nuclear medicine examinations

Radiation Protection Dosimetry ◽

10.1093/rpd/ncv127 ◽

2015 ◽

Vol 165 (1-4) ◽

pp. 39-42 ◽

Cited By ~ 6

Author(s):

M. Balonov ◽

V. Golikov ◽

S. Kalnitsky ◽

I. Zvonova ◽

L. Chipiga ◽

...

Keyword(s):

Nuclear Medicine ◽

X Ray ◽

Practical Guidance

Download Full-text

Using 100- instead of 120-kVp computed tomography to diagnose pulmonary embolism almost halves the radiation dose with preserved diagnostic quality

Acta Radiologica ◽

10.3109/02841850903505222 ◽

2010 ◽

Vol 51 (3) ◽

pp. 260-270 ◽

Cited By ~ 24

Author(s):

Peter Björkdahl ◽

Ulf Nyman

Keyword(s):

Computed Tomography ◽

Pulmonary Embolism ◽

Image Quality ◽

Radiation Dose ◽

Effective Dose ◽

Ct Number ◽

Subjective Image Quality ◽

Diagnostic Quality ◽

X Ray ◽

Tube Potential

Background: Concern has been raised regarding the mounting collective radiation doses from computed tomography (CT), increasing the risk of radiation-induced cancers in exposed populations. Purpose: To compare radiation dose and image quality in a chest phantom and in patients for the diagnosis of pulmonary embolism (PE) at 100 and 120 peak kilovoltage (kVp) using 16-multichannel detector computed tomography (MDCT). Material and Methods: A 20-ml syringe containing 12 mg I/ml was scanned in a chest phantom at 100/120 kVp and 25 milliampere seconds (mAs). Consecutive patients underwent 100 kVp ( n = 50) and 120 kVp ( n = 50) 16-MDCT using a “quality reference” effective mAs of 100, 300 mg I/kg, and a 12-s injection duration. Attenuation (CT number), image noise (1 standard deviation), and contrast-to-noise ratio (CNR; fresh clot = 70 HU) of the contrast medium syringe and pulmonary arteries were evaluated on 3-mm-thick slices. Subjective image quality was assessed. Computed tomography dose index (CTDIvol) and dose–length product (DLP) were presented by the CT software, and effective dose was estimated. Results: Mean values in the chest phantom and patients changed as follows when X-ray tube potential decreased from 120 to 100 kVp: attenuation +23% and +40%, noise +38% and +48%, CNR −6% and 0%, and CTDIvol −38% and −40%, respectively. Mean DLP and effective dose in the patients decreased by 42% and 45%, respectively. Subjective image quality was excellent or adequate in 49/48 patients at 100/120 kVp. No patient with a negative CT had any thromboembolism diagnosed during 3-month follow-up. Conclusion: By reducing X-ray tube potential from 120 to 100 kVp, while keeping all other scanning parameters unchanged, the radiation dose to the patient may be almost halved without deterioration of diagnostic quality, which may be of particular benefit in young individuals.

Download Full-text

Diagnostic and therapeutic applications of radiopharmaceutical agents: The medical use of radioactive iodine (I-131) therapy for hyperthyroidism treatments.

(IJRE) International Journal of Research and Ethics (ISSN 2665-7481) ◽

10.51766/ijre.v3i1.7 ◽

2021 ◽

Vol 3 (1) ◽

Author(s):

Hasnae WATLA ◽

Mohamed LAHKIM ◽

Mohamed Amine CHAD

Keyword(s):

Nuclear Medicine ◽

Effective Dose ◽

Radioactive Iodine ◽

Minimum Effective Dose ◽

Therapeutic Aspect ◽

Therapeutic Applications ◽

Medical Centers ◽

Iodine 131 ◽

Radiopharmaceutical Agents

The treatment of hyperthyroidism with iodine-131 has been recognized on nuclear medicine as simple, effective and inexpensive, this kind of radiopharmaceutical is chosen by the majority of medical centers by administering a minimum effective dose enabling euthyroidism to be easily compensated as quickly as possible while avoiding radiation problems. In this mini_review, we are going to explain the diagnostic and therapeutic aspect of radiopharmaceuticals by taking an example of radioiodine I-131 and its role on hyperthyroidism treatment .

Download Full-text